Skip to main content
Have a personal or library account? Click to login
Design, development and evaluation of novel nanoemulsion formulations for transdermal potential of celecoxib Cover

Design, development and evaluation of novel nanoemulsion formulations for transdermal potential of celecoxib

Open Access
|Sep 2007

References

  1. E. Escibano, A. C. Calpena, J. Queralt, R. Obach and J. Domenech, Assessment of diclofenac permeation with different formulations: anti-inflammatory study of a selected formula,(2003) 203--210; DOI: 10.1016/S0928-0987(03)00103-9.
  2. Gaurel, A. M. Martel and J. Castaner, Celecoxib, anti-inflammatory, cyclo-oxygenase-2 inhibitor,(1997) 711--714.
  3. K. A. Walters,, in(Eds. J. Hadgraft and R. H. Guy), Marcel Dekker, New York 1989, pp. 197--246.
  4. D. W. Osborne, A. J. Ward and K. J. Neil, Microemulsions as topical delivery vehicles:transdermal studies of a model hydrophilic drug,(1991) 450--454.
  5. M. Trotta, F. Pattarino and M. R. Gasco, Influence of counter ions on the skin permeation of methotrexate from water-oil microemulsions,(1996) 135--140; DOI: 10.1016/0031-6865(96)00003-9.
  6. S. Shafiq, S. Faiyaz, T. Sushma, J. A. Farhan, R. K. Khar and M. Ali, Design and development of ramipril nanoemulsion formulation: In vitro and in vivo assessment,(2007) 28--44; DOI: 10.1166/jbn.2007.008.
  7. S. Shafiq, S. Faiyaz, T. Sushma, J. A. Farhan, R. K. Khar and M. Ali, Development and bioavailability assessment of ramipril nanoemulsion formulation,(2007) 227--243; DOI: org/10.1016/j.ejpb.2006.10.014.
  8. M. B. Delgado-Charro, G. Iglesias-Vilas, J. Blanco-Mendez, M. J. Lopez-Quintela, M. A. Marty and J. P. Guy, Delivery of a hydrophilic solute through the skin from novel microemulsion systems,(1997) 37--42; DOI: 10.1016/S0939-6411(96)00016-1.
  9. M. Kreilgaard, E. J. Pedersen and J. W. Jaroszewski, NMR characterization and transdermal drug delivery potentials of microemulsion systems,(2000) 421--433; DOI: 10.1016/S0168-3659(00)00325-4.
  10. P. J. Lee, R. Langer and V. P. Shastri, Novel microemulsion enhancer formulation for simultaneous transdermal delivery of hydrophilic and hydrophobic drugs,(2003) 264--269; DOI: 10.1023/A:1022283423116.
  11. M. Kreilgaard, Dermal pharmacokinetics of microemulsion formulations determined bymicrodialysis,(2001) 367--373; DOI: 10.1023/A:1011067300397.
  12. M. Kreilgaard, M. J. B. Kemme, J. Burggraaf, R. C. Schoemaker and A. F. Cohen, Influence of a microemulsion vehicle on cutaneous bioequivalence of a lipophilic model drug assessed by microdialysis and pharmacodynamics,(2001) 593--599; DOI: 10.1023/A:1011068907416.
  13. M. R. Gasco, M. Gallarate and F. Pattarino,permeation of zelaic acid from viscosized microemulsions,(1991) 193--196; DOI: 10.1016/0378-5173(91)90361-Q.
  14. K. Kriwet and C. C. Muller-Goymann, Diclofenac release from phospholipids drug systems and permeation through excised human stratum corneum,(1995) 231--242; DOI: 10.1016/0378-5173(95)00130-B.
  15. S. Baboota, F. Shakeel, A. Ahuja, J. Ali, S. Shafiq and S. Ahmed, Development and validation of stability indicating HPLC method for analysis of Celecoxib in bulk drug and microemulsion formulations,(in press).
  16. N. J. Van Abbe, P. Nicholas and E. Boon, Exaggerated exposure in topical irritancy and sensitization testing,(1975) 173--187.
  17. C. A. Winter, Anti-inflammatory testing methods: Comparative evaluation of indomethacin and other agents,,(1965) 190--202.
  18. M. N. Gosh,, 3ed., Hilton and Co., Kolkata 2005, p. 192.
  19. D. Q. M. Craig, S. A. Barker, D. Banning and S. W. Booth, An investigation into the mechanisms of self-emulsification using particle size analysis and low frequency dielectric spectroscopy,(1995) 103--110; DOI: 10.1016/0378-5173(94)00222-Q.
  20. K. Kawakami, T. Yoshikawa, Y. Moroto, E. Kanaoka, K. Takahashi, Y. Nishihara and K. Masuda, Microemulsion formulation for enhanced absorption of poorly soluble drugs I. Prescription design,(2002) 65--74; DOI: 10.1016/S0168-3659(02)00049-4.
  21. M. J. Lawrence and G. D. Rees, Microemulsion-based media as novel drug delivery systems,(2000) 89--121; DOI: 10.1016/S0169-409X(00)00103-4.
  22. W. Warisnoicharoen, A. B. Lansley and M. J. Lawrence, Light scattering investigations on dilute non-ionic oil-in-water microemulsions,(2000) article 12; DOI: 10.1208/ps020212.
  23. L. Ping, A. Ghosh, R. F. Wagner, S. Krill, Y. M. Joshi and A. T. M. Serajuddin, Effect of combined use of nonionic surfactant on formation of oil-in-water microemulsions,(2005) 27--34; DOI: 10.1016/jijpharm.2004.08.024.
  24. K. Shinoda and H. Kunieda,, in(Eds. K. Shinoda and H. H. Kunieda), Marcel Dekker, New York 1983, pp. 337--367.
  25. N. J. Kale and A. V. Allen, Studies on microemulsions using Brij-96 as surfactant and glycerin, ethylene glycol and propylene glycol as cosurfactants,(1998) 87--93; DOI: 10. 1016/0378-5173(89)90296-2.
  26. D. Thacrodi and R. K. Panduranga, Transdermal absorption of nifedipine from microemulsions of lipophilic skin penetration enhancers,(1994) 235--240; DOI: 10.1016/0378--5173(94)90346-8.
DOI: https://doi.org/10.2478/v10007-007-0025-5 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Language: English, Croatian
Page range: 315 - 332
Published on: Sep 18, 2007
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Related subjects:

© 2007 Sanjula Baboota, Faiyaz Shakeel, Alka Ahuja, Javed Ali, Sheikh Shafiq, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons License.